Related references
Note: Only part of the references are listed.Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art
Maria Luisa Bondi et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution
Maria Luisa Bondi et al.
NANOMEDICINE (2010)
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
Reinhard Gabathuler
NEUROBIOLOGY OF DISEASE (2010)
Recent Advances in Medicinal Chemistry and Pharmaceutical Technology-Strategies for Drug Delivery to the Brain
Nunzio Denora et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB)
Karsten Ulbrich et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Lipid nanoparticles for parenteral delivery of actives
Medha D. Joshi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations
Kaili Hu et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution
Anna Valeria Vergoni et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)
Evolving lipid-based delivery systems in the management of neoplastic disease
Iuliana Shapira et al.
ONCOLOGY REVIEWS (2009)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier
Lihong Li et al.
BIOMATERIALS (2008)
Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier
Lihong Liu et al.
BIOPOLYMERS (2008)
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
Barnabas Wilson et al.
BRAIN RESEARCH (2008)
The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Ludenne Juillerat-Jeanneret
DRUG DISCOVERY TODAY (2008)
Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers
Elena V. Batrakova et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Potential of solid lipid nanoparticles in brain targeting
Indu Pal Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain
Vandana Soni et al.
JOURNAL OF DRUG TARGETING (2008)
Nanovehicular intracellular delivery systems
Ales Prokop et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Engineering biodegradable polyester particles with specific drug targeting and drug release properties
Farahidah Mohamed et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Pharmacokinetics and biodistribution of nanoparticles
Shyh-Dar Li et al.
MOLECULAR PHARMACEUTICS (2008)
Emerging nanopharmaceuticals
Willie E. Bawarski et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2008)
Biocompatible polymeric micelles with polysorbate 80 for use in brain targeting
E. F. Craparo et al.
NANOTECHNOLOGY (2008)
Polymeric nanomedicine for cancer therapy
Jae Hyung Park et al.
PROGRESS IN POLYMER SCIENCE (2008)
Functional amphiphilic and biodegradable copolymers for intravenous vectorisation
K. Van Butsele et al.
POLYMER (2007)
Targeting the central nervous system:: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123
G. Tosi et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Surface modification of RGD-Liposomes for selective drug delivery to monocytes/neutrophils in brain
Jing Qin et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2007)
Solid lipid nanoparticles for targeted brain drug delivery
Paolo Blasi et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain
Yashwant Gupta et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
shRNA and siRNA delivery to the brain
William M. Pardridge
ADVANCED DRUG DELIVERY REVIEWS (2007)
Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells
Yong Hu et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier
Gabriel A. Silva
SURGICAL NEUROLOGY (2007)
Micellar nanocarriers: Pharmaceutical perspectives
V. P. Torchilin
PHARMACEUTICAL RESEARCH (2007)
PEG-PLA block copolymer as potential drug carrier: Preparation and characterization
Shimon Ben-Shabat et al.
MACROMOLECULAR BIOSCIENCE (2006)
Multifunctional nanocarriers
Vladimir P. Torchilin
ADVANCED DRUG DELIVERY REVIEWS (2006)
Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration
Kopparam Manjunath et al.
JOURNAL OF DRUG TARGETING (2006)
Endocytosis at the blood-brain barrier: From basic understanding to drug delivery strategies
Mathew W. Smith et al.
JOURNAL OF DRUG TARGETING (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Delivering drugs to the central nervous system: A medicinal chemistry or a pharmaceutical technology issue?
Maurizio Ricci et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26
Y Aktas et al.
BIOCONJUGATE CHEMISTRY (2005)
Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration
K Manjunath et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration
D Das et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier
W Lu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Gene therapy of the brain - The trans-vascular approach
F Schlachetzki et al.
NEUROLOGY (2004)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
Organ-specific expression of the lacZ gene controlled by the opsin promoter after intravenous gene administration in adult mice
CN Zhu et al.
JOURNAL OF GENE MEDICINE (2004)
New technologies for drug delivery across the blood brain barrier
AV Kabanov et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer
Y Zhang et al.
CLINICAL CANCER RESEARCH (2004)
Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion
T Gosk et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Solid lipid nanoparticles for parenteral drug delivery
SA Wissing et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Novel delivery systems for drug targeting to the brain
JS Reddy et al.
DRUGS OF THE FUTURE (2004)
Brain uptake of thiamine-coated nanoparticles
PR Lockman et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis
J Schmidt et al.
BRAIN (2003)
Advancing the field of drug delivery: Taking aim at cancer
MA Moses et al.
CANCER CELL (2003)
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier
J Kreuter et al.
JOURNAL OF DRUG TARGETING (2002)
Nanoparticulate systems for brain delivery of drugs
J Kreuter
ADVANCED DRUG DELIVERY REVIEWS (2001)
Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system
A Friese et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)